1833P Concurrent high-dose IV Vitamin C (IVC) and docetaxel for metastatic castrate-resistant prostate cancer (mCRPC): A randomized, placebo-controlled, double-blind phase II trial von Paller, C., Zahurek, M., Mandl, A., Rudek, M., Heath, E., Marshall, C.H., Markowski, M.C., Lalji, A., Metri, N., Hoimes, C.J., Taksey, J., Durham, J., Kelly, W., Antonarakis, E.S., Eisenberger, M., Carducci, M.A., Denmeade, S., Levine, M.

Volltext

Allergy test results of a rural and small-city population compared with those of an urban population von Taksey, J, Craig, T J

Volltext

FERTILITY AFTER CHEMOTHERAPY FOR TESTICULAR CANCER von TAKSEY, J., BISSADA, N. K., CHAUDHARY, U. B.

Volltext

Case 3. Small-cell carcinoma of the stomach von CHAUDHARY, Uzair B, TAKSEY, Jason D, JOHNSON, R. Duren, LEWIN, David N

Volltext

FERTILITY AFTER CHEMOTHERAPY FOR TESTICULAR CANCER von Taksey, J., Bissada, N. K., Chaudhary, U. B.

Volltext

Randomized placebo-controlled trial of intravenous vitamin C plus docetaxel in metastatic prostate cancer von Paller, Channing Judith, Zahurak, Marianna, Heath, Elisabeth I., Kelly, William Kevin, Hoimes, Christopher J., Taksey, Jason David, Marshall, Catherine Handy, Markowski, Mark Christopher, Barata, Pedro C., Rudek, Michelle A., Nauroth, Julie, Wang, Lin, Durham, Jennifer N., Eisenberger, Mario A., Carducci, Michael Anthony, Denmeade, Samuel R., Levine, Mark

Volltext

High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase 2 Trial von Paller, Channing J, Zahurak, Marianna L, Mandl, Adel, Metri, Nicole A, Lalji, Aliya, Heath, Elisabeth, Kelly, William K, Hoimes, Christopher, Barata, Pedro, Taksey, Jason, Garrison, Dominique A, Patra, Kartick, Milne, Ginger L, Anders, Nicole M, Nauroth, Julie M, Durham, Jennifer N, Marshall, Catherine H, Markowski, Mark C, Eisenberger, Mario A, Antonarakis, Emmanuel S, Carducci, Michael A, Denmeade, Samuel R, Levine, Mark

Volltext

High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial von Paller, Channing J., Zahurak, Marianna L., Mandl, Adel, Metri, Nicole A., Lalji, Aliya, Heath, Elisabeth, Kelly, William K., Hoimes, Christopher, Barata, Pedro, Taksey, Jason, Garrison, Dominique A., Patra, Kartick, Milne, Ginger L., Anders, Nicole M., Nauroth, Julie M., Durham, Jennifer N., Marshall, Catherine H., Markowski, Mark C., Eisenberger, Mario A., Antonarakis, Emmanuel S., Carducci, Michael A., Denmeade, Samuel R., Levine, Mark

Volltext

Effect of bisphosphonates (Bis) combined with sunitinib (Su) on the response rate (RR), progression-free survival (PFS), and overall survival (OS) of patients (pts) with bone metas... von Keizman, Daniel, Ish-Shalom, Maya, Taksey, Jason David, Pili, Roberto, Hammers, Hans J., Eisenberger, Mario A., Boursi, Ben, Berger, Raanan, Maimon, Natalie, Gottfried, Maya, Hayat, Henry, Peer, Avivit, Kovel, Svetlana, Sella, Avishay, Carducci, Michael Anthony

Volltext

Influence of risk factors for renal cell carcinoma (RCC) on outcome of patients (pts) with metastatic disease treated with sunitinib von Keizman, Daniel, Ish-Shalom, Maya, Taksey, Jason David, Pili, Roberto, Hammers, Hans J., Eisenberger, Mario A., Boursi, Ben, Berger, Raanan, Maimon, Natalie, Gottfried, Maya, Hayat, Henry, Peer, Avivit, Kovel, Svetlana, Sella, Avishay, Carducci, Michael Anthony

Volltext